Literature DB >> 8611402

Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats.

I L Cameron1, J Garza, W E Hardman.   

Abstract

Sprague-Dawley rats were given eight weekly subcutaneous injections of 1,2-dimethylhydrazine (DMH) or of vehicle then were sacrificed at 1, 5 or 24 weeks after the last injection of DMH. The locations of pre-existing aggregates of lymphoid nodules (ALNs), the location and multiplicity (size) of aberrant crypt foci (ACF), and the locations of tumours in the colon were determined. A trimodal distribution of pre-existing ALNs along the length of the colon was significantly correlated with the timodal distribution of DMH-induced adenocarcinomas (ACs). A unimodal peak in ACF of all sizes occurred between the sites of two distal ALNs. Thus, the distribution of ACF at 1 or 5 weeks did not correlate with distribution of AC found at 24 weeks. Of the 2640 ACF observed at 1 or at 5 weeks, none were found in the proximal 25% of the colon where ACs eventually occurred. It was concluded that: (1) ALNs play a promotional role in AC formation; (2) the ACs which form in the proximal quarter of the colon seldom if ever form via an ACF precursor; and (3) the location, the number and the size of ACF observed early after DMH exposure did not correlate with the location or predict the incidence of ACs which eventually formed in the colon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611402      PMCID: PMC2074251          DOI: 10.1038/bjc.1996.159

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods.

Authors:  B Tudek; R P Bird; W R Bruce
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

2.  Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.

Authors:  G M Williams; K Watanabe
Journal:  J Natl Cancer Inst       Date:  1978-07       Impact factor: 13.506

3.  Large intestinal carcinogenesis. II. Histogenesis and unusual features of low-dose azoxymethane-induced carcinomas in F344 rats.

Authors:  A M Shamsuddin; M L Hogan
Journal:  J Natl Cancer Inst       Date:  1984-12       Impact factor: 13.506

4.  The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumor incidence.

Authors:  E E Deschner; J S Lytle; G Wong; J F Ruperto; H L Newmark
Journal:  Cancer       Date:  1990-12-01       Impact factor: 6.860

5.  Gut-associated lymphoid tissue and 1,2-dimethylhydrazine intestinal tumors in the rat: an histological and immunoenzymatic study.

Authors:  M S Martin; A Hammann; F Martin
Journal:  Int J Cancer       Date:  1986-07-15       Impact factor: 7.396

6.  Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence.

Authors:  W E Hardman; I L Cameron; D W Heitman; E Contreras
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

7.  Changes in intestinal mucosa above lymph follicles during carcinogenesis in rats. A light and electron microscopic study.

Authors:  F Shimamoto; E Vollmer
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

8.  Aberrant crypts: potential preneoplastic lesions in the murine colon.

Authors:  E A McLellan; R P Bird
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

9.  Morphology and distribution of 1,2-dimethylhydrazine dihydrochloride-induced colon tumors and their relationship to gut-associated lymphoid tissue in the rat.

Authors:  K M Nauss; M Locniskar; T Pavlina; P M Newberne
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

10.  Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis.

Authors:  G Caderni; A Giannini; L Lancioni; C Luceri; A Biggeri; P Dolara
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more
  4 in total

1.  Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.

Authors:  Robert E Carroll; Robert A Goodlad; Aleksandra J Poole; Angela L Tyner; R Brooks Robey; Steven M Swanson; Terry G Unterman
Journal:  Growth Horm IGF Res       Date:  2009-04-29       Impact factor: 2.372

2.  Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis.

Authors:  C J Barnes; I L Cameron; W E Hardman; M Lee
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

3.  A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat.

Authors:  B S Han; C B Park; N Takasuka; A Naito; K Sekine; E Nomura; H Taniguchi; T Tsuno; H Tsuda
Journal:  Jpn J Cancer Res       Date:  2001-04

4.  Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.

Authors:  Julia Koerner; Thomas Brunner; Marcus Groettrup
Journal:  Oncotarget       Date:  2017-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.